Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
A completed pilot study evaluating motion correction techniques for dynamic contrast-enhanced MRI in patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with docetaxel in ovarian, fallopian tube, and primary peritoneal cancers has …
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors [Phase 2]
Phase 2 study of BI-2536 in patients with recurrent or metastatic solid tumors, including breast cancer, endometrial cancer, head and neck c…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating sequential chemotherapy for patients with residual disease after surgery for advanced ovarian cance…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
This clinical trial update describes a laboratory study aimed at predicting tumor response to chemotherapy in patients with fallopian tube c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Feeding Schedules After Surgery in Patients With Gynecologic Cancer [NA]
An update on a clinical trial investigating feeding schedules after surgery in patients with gynecologic cancer. The current status is liste…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with or without bevacizumab in advanced ovarian epithelial, primary peritoneal, or fallo…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery [Phase 3]
A Phase 3 trial comparing high-dose chemotherapy with standard chemotherapy in patients with stage III or stage IV ovarian epithelial cancer…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors [NA]
This clinical trial update describes the etoposide, carboplatin, and bleomycin regimen being studied in young patients undergoing surgery fo…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors [Phase 3]
Phase 3 clinical trial evaluating observation and/or combination chemotherapy after surgery or biopsy in young patients with extracranial ge…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy [Phase 3]
A phase 3 clinical trial update describes monoclonal antibody therapy for patients with ovarian cancer or primary peritoneal cancer in remis…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating two different schedules of carboplatin, paclitaxel, and gemcitabine with surgery for newly diagnosed adv…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [Phase 2]
Clinical trial update: a Phase 2 study of methotrexate plus dipyridamole in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase I/II study of CP-4055 in platinum-resistant ovarian cancer has completed, as reported by sponsor Clavis Pharma.
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: The Effect of TRA-8 on Ovarian Cancer Tissue
This completed study evaluated the effect of TRA-8 on ovarian cancer tissue, reporting tissue-level results from a University of Alabama at …
-
CLINICAL_TRIALS withdrawal · 2013-09-05Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial of FR901228 for relapsed or refractory advanced ovarian epithelial cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer [NA]
Clinical trial update for hyperthermic intraperitoneal chemotherapy using carboplatin in first recurrence ovarian cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing erlotinib to observation in patients who completed first-line chemotherapy for ovarian, fallopian tube, or primary…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of Bryostatin 1 in combination with Cisplatin for advanced recurrent or residual ovarian epithelial, fallopian tube, or primar…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial comparing carboplatin with or without thalidomide in ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer [NA]
This clinical trial update describes a study investigating whether DNA mutations can predict the effect of external-beam radiation therapy i…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 clinical trial evaluating liposome-encapsulated doxorubicin citrate with or without gemcitabine hydrochloride in patients with ovari…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 2]
This entry covers a Phase 2 trial of paclitaxel and cisplatin as first-line therapy for ovarian epithelial cancer across stages I-IV.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
A Cancer Research UK study update describes a trial investigating genetic and environmental factors in patients with ovarian cancer in the E…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of Yondelis (trabectedin) in patients with advanced relapsed ovarian cancer. The st…